10.50 - 11.12
3.81 - 12.83
1.80M / 1.60M (Avg.)
158.14 | 0.07
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
60.35%
EBIT growth above 1.5x OR's 15.15%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
60.35%
Operating income growth above 1.5x OR's 7.56%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
60.48%
Net income growth above 1.5x OR's 26.20%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
60.51%
EPS growth above 1.5x OR's 21.43%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
60.51%
Diluted EPS growth above 1.5x OR's 21.43%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.09%
Share reduction more than 1.5x OR's 0.41%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.09%
Diluted share reduction more than 1.5x OR's 0.35%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
34.92%
OCF growth above 1.5x OR's 11.49%. David Dodd would confirm a clear edge in underlying cash generation.
66.17%
Positive FCF growth while OR is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-74.24%
Negative 10Y OCF/share CAGR while OR stands at 273.05%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-74.24%
Negative 5Y OCF/share CAGR while OR is at 192.29%. Joel Greenblatt would question the firm’s operational model or cost structure.
-74.24%
Negative 3Y OCF/share CAGR while OR stands at 22738.42%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-344.29%
Negative 10Y net income/share CAGR while OR is at 301.80%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-344.29%
Negative 5Y net income/share CAGR while OR is 117.59%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-344.29%
Negative 3Y CAGR while OR is 86.14%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-45.15%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-45.15%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-45.15%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
41.21%
AR growth well above OR's 8.62%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-6.11%
Negative asset growth while OR invests at 3.85%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.61%
We have a declining book value while OR shows 5.86%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-60.86%
We cut SG&A while OR invests at 19.74%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.